G&B specializes exclusively in intellectual property law, particularly concentrating in patents, trademarks and copyrights. G&B maintains an active docket in all aspects and stages of intellectual property practice, including patent prosecution and licensing, post-grant procedures, litigation, and Hatch-Waxman.
G&B’s Pharmaceutical Practice Group is highly experienced with all aspects of Hatch-Waxman, including developing patent strategies for generic companies, preparing Notice Letters, litigation, and negotiating settlements. Not content to work within rigid confines, G&B attorneys have the flexibility to employ creative methods to resolve disputes, including cooperative and creative negotiations; use of FDA citizen petitions; and post-grant procedures.
Our team is uniquely qualified to represent petitioners and patent owners in Inter Partes Review proceedings (IPR), and Post Grant Review proceedings (PGR). Our team filed the nation’s first PGR petition on a pharmaceutical patent.
In addition to our patent practitioners who have significant and longstanding experience representing patentees and third party requestors in reexamination proceedings, our team includes several former administrative patent judges of the Board of Patent Appeals and Interferences (now the “Patent Trial and Appeal Board”), whose experience is directly applicable to the Board who will be handling the newly created post-grant proceedings. Further, our team includes practitioners with significant experience with interference proceedings, which are also conducted before the same Board as the newly created post-grant proceedings.
G&B represents a broad range of clients encompassing a broad spectrum of technical areas, from large and established multinational corporations to start-up companies seeking intellectual property guidance for the first time. Our client base spans the globe, with major clientele from every continent (except Antarctica), including the United States, India, Europe, and Japan.